M. Elisabeth· @ChildrenNeedUs_ · X·· 2026-04-21Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
daraxonrasib ± GnP · mono ORR 47%; +GnP ORR 55%, DCR 90%
Body
#AACR26
#AACR2026
#PancreaticCancer
Just to be clear, the study consisted of 16 patients and eight of those patients had T cell responses.
7 of those eight are still alive six years later.
Of those who didn’t mount a T cell response, two of those eight are alive. It’s still
Heat 0 · 0 likes · 0 replies · 0 reposts
Source: M. Elisabeth · x.com